Stock futures were falling on Wednesday after Google parent Alphabet reported quarterly revenue that missed expectations and as investors awaited talks between Trump and Xi Jinping as the countries ...

Robert F. Kennedy Jr.’s HHS nomination moves to a full Senate vote; Donald Trump’s tariff war sparks China-related concerns for biopharma; Pfizer, Merck and more announce Q4 and 2024 earnings; and the ...

Novo Nordisk's U.S.-listed shares are rising 4% in premarket trading after the Ozempic and Wegovy maker's better-than-estimated quarterly results offset slower 2025 sales growth projections amid ...

EU mid-market update: Trump adds Middle East tensions to macro picture as trade war keeps volatility high; Novo Nordisk rises ...

As per provisional closing, the S&P BSE Sensex, tumbled 312.53 points or 0.40% to 78,271.28. The Nifty 50 index fell 42.95 points or 0.18% to 23,696.30.

European shares were flat in early trade on Wednesday, as gains led by healthcare stocks following drugmaker Novo Nordisk's ...

Wegovy maker Novo Nordisk is not immune to tariffs U.S. President Donald Trump is threatening to levy on the European Union, ...

Investors shrugged off comments from President Donald Trump that the U.S. would like to take over the war-ravaged Gaza Strip ...

The "BPO Services Top 5 Emerging Markets Industry Guide 2019-2028" report has been added to ResearchAndMarkets.com's offering.The Emerging 5 BPO Services industry profile provides top-line qualitative ...

Despite trade tensions, US markets rebounded on Tuesday, recovering from steep losses on Monday. The S&P 500 climbed 0.7%, the NASDAQ Composite jumped 1.4%, and the Dow Jones Industrial Average edged ...

The Danish pharmaceutical company expects sales growth to slow this year as capacity constraints, intensifying competition ...

With the respite in U.S. tariffs on key countries, investors could turn their attention to earnings. But Alphabet earnings ...